Literature DB >> 8102854

CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.

A N Phillips1, C A Sabin, J Elford, M Bofill, C A Lee, G Janossy.   

Abstract

OBJECTIVE: To assess the ability of the CD8 lymphocyte count and immunoglobulin (Ig) A level, measured at the early stage of HIV infection when the CD4 lymphocyte count remains relatively high, to predict the future rate of CD4 lymphocyte loss and hence the risk of AIDS.
DESIGN: Cohort of recently infected haemophiliacs with relatively high CD4 lymphocyte counts followed for up to 8.5 years from baseline measurement of CD8 lymphocyte counts and IgA levels.
SETTING: A regional haemophilia centre based in a major teaching hospital. PATIENTS: Eighty-four of 111 patients with haemophilia who seroconverted to HIV between 1979 and 1985 in whom CD8 lymphocyte counts and IgA levels were measured soon after seroconversion (mean, 2.7 years; maximum, 5 years) while CD4 lymphocyte counts remained relatively high (median, 600 x 10(6)/l; minimum, 300 x 10(6)/l). OUTCOME MEASURES: Development of severe immunodeficiency defined by a CD4 lymphocyte count falling below 50 x 10(6)/l, and AIDS.
RESULTS: Individuals with high CD8 counts (P < 0.008) and high IgA levels (P < 0.003) at baseline experienced a more rapid rate of CD4 lymphocyte loss than those with low baseline levels. A score was derived to combine the predictive ability of CD8 count and IgA level. Estimated proportions with CD4 counts below 50 x 10(6)/l after 8 years of follow-up were 100, 30 and 14% for those with high, intermediate and low baseline scores, respectively. The CD8/IgA score showed similar ability to predict the future occurrence of AIDS (P < 0.0001; log-rank test).
CONCLUSION: Immune activation seen in HIV infection, as reflected by raised CD8 counts and IgA levels, appears to be linked to the process of CD4 lymphocyte depletion. Measurement of these markers in the years following infection, when CD4 lymphocyte counts remain high, provides a first indication of a patient's long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102854     DOI: 10.1097/00002030-199307000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Immunological markers of disease progression in patients infected with the human immunodeficiency virus.

Authors:  J M Pascale; M D Isaacs; P Contreras; B Gomez; L Lozano; E Austin; M C De Martin; R L Gregory; G L McLaughlin; A Amador
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.

Authors:  Hiromi Imamichi; Richard A Lempicki; Joseph W Adelsberger; Rebecca B Hasley; Alice Rosenberg; Gregg Roby; Catherine A Rehm; Amy Nelson; Sonya Krishnan; Mark Pavlick; Christian J Woods; Michael W Baseler; H Clifford Lane
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

3.  Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.

Authors:  Krishanthi Subramaniam; Neil French; Liise-Anne Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.

Authors:  Elizabeth M Krantz; Katherine Huppler Hullsiek; Jason F Okulicz; Amy C Weintrob; Brian K Agan; Nancy F Crum-Cianflone; Anuradha Ganesan; Tomas M Ferguson; Braden R Hale
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

5.  Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

Authors:  S Resino; J Navarro; J M Bellón; D Gurbindo; J A León; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.

Authors:  Meenakshi Sachdeva; Margaret A Fischl; Rajendra Pahwa; Naresh Sachdeva; Savita Pahwa
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

7.  CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.

Authors:  Savita Pahwa; Jennifer S Read; Wanrong Yin; Yvonne Matthews; William Shearer; Clemente Diaz; Kenneth Rich; Hermann Mendez; Bruce Thompson
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

8.  Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.

Authors:  Shinobu Tatsunami; Junichi Mimaya; Akira Shirahata; Jiří Zelinka; Ivana Horová; Jugo Hanai; Yutaka Nishina; Katsumi Ohira; Masashi Taki
Journal:  Int J Hematol       Date:  2008-08-02       Impact factor: 2.490

Review 9.  Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Authors:  Emily S Ford; Camille E Puronen; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

10.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.